Shandong Mimei Biotechnology Co.,Ltd. was established in 2019, located in No.1 Yudong Road, Dongcheng Street, Linqu County, Weifang City, Shandong Province, with a registered capital of 105 million RMB and a total project investment of 500 million RMB. It covers a total area of 140,000 m2, with a planned total construction area of 120,000m2. It mainly produces Pullulan polysaccharide and a series of co-products, with an annual output of 3000 tons of Pullulan polysaccharide, 10 billion Pullulan capsules and 80 million Pullulan oral thin films, and an annual sales revenue of 1 billion RMB. It is a professional large-scale production base for Pullulan polysaccharide in China, and is a key project of Shandong Province.
more >
Year of Establishment:
2019
Total Assets(USD):
500,000 to 99,999,999
Total Number of Staff:
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
OEM,ODM,Own Brand
Annual Turnover(USD):
More than 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Patents and Copyrights: